Melasma is a chronic pigmentation disorder that causes symmetrical brown or grey-brown patches on the face, most commonly affecting areas such as the cheeks, forehead, upper lip, and chin. It is particularly common in Asian skin types, where increased melanin activity makes the skin more prone to pigmentation changes.
The condition is often triggered or worsened by a combination of sun exposure, hormonal fluctuations (such as pregnancy or oral contraceptive use), and genetic predisposition. While many patients hope for a complete and permanent cure, it is important to understand that melasma is typically a long-term condition that can be effectively managed but not always fully eliminated.
Because of its complex nature, successful treatment usually requires a combination approach rather than relying on a single therapy. If you are considering professional help, visiting a trusted melasma clinic in Singapore can help ensure a personalised and evidence-based treatment plan tailored to your skin condition.
Why Melasma Is Difficult to Treat and Prone to Recurrence
Melasma can be particularly challenging to manage because it is a complex condition involving multiple layers of the skin and different biological pathways. Unlike simple surface pigmentation, melasma often extends deeper into the skin and is influenced by factors such as chronic sun exposure, visible light, heat, and ongoing skin inflammation. Even small triggers, such as inadequate sun protection or overly aggressive skincare treatments, can lead to flare-ups or darkening of existing patches.
This makes the condition highly prone to recurrence, even after initial improvement with treatment. Many patients notice that pigmentation can return gradually over time if maintenance strategies are not followed consistently. In addition, individuals with melasma often have heightened skin sensitivity, which limits the use of strong exfoliating agents or intensive procedures. As a result, effective management requires a careful, long-term approach that balances pigment control with skin barrier protection, rather than relying on short-term or aggressive interventions.
Topical Creams as the Foundation of Melasma Treatment
Topical treatments are usually considered the first-line and most essential component in managing melasma. These creams work by targeting different stages of pigment production in the skin, helping to gradually reduce existing pigmentation while preventing new spots from forming.
Commonly used ingredients include hydroquinone, which inhibits melanin production and is often used in short cycles under medical supervision; retinoids, which help increase skin cell turnover and improve the penetration of other active ingredients; and azelaic acid or niacinamide, which have anti-inflammatory and pigment-modulating effects. More recently, tranexamic acid in topical form has also gained popularity for its role in reducing pigmentation activity.
Consistency is key when using topical therapy, as results are typically gradual and may take several weeks to months before visible improvement is seen. However, because melasma-prone skin is often sensitive, treatment must be carefully balanced to avoid irritation, which can paradoxically worsen pigmentation. For this reason, topical regimens are usually customised based on skin type, severity of melasma, and tolerance, and are often used as the foundation upon which other treatment modalities are added.
Oral Medications for Melasma
Oral medications have become an increasingly important option in the management of melasma, particularly for patients with more stubborn or recurrent pigmentation. The most commonly used oral treatment is tranexamic acid, which works by reducing pigment production pathways and also addressing the vascular and inflammatory components that contribute to melasma. Unlike topical treatments, oral therapy works systemically, which can make it effective for cases that do not respond adequately to creams alone.
Before starting oral treatment, a proper medical assessment is essential to ensure suitability and safety, as not all patients are appropriate candidates. When used correctly under medical supervision, oral tranexamic acid can be a valuable adjunct to topical therapy, often enhancing overall treatment outcomes.
Key points about oral medications for melasma:
- Most commonly used option: oral tranexamic acid
- Works by reducing pigment activity and inflammation pathways
- Typically used as an adjunct, not a standalone treatment
- Requires medical screening before initiation
- Not suitable for everyone (individual risk assessment needed)
- Results may improve over several weeks of consistent use
- Maintenance and combination therapy are often needed to sustain results
Laser and Energy-Based Treatments for Melasma
Laser and energy-based treatments can play a supportive role in selected cases of melasma, but they must be used cautiously. Unlike other pigmentation conditions, melasma is sensitive to heat and inflammation, which means inappropriate laser settings or overly aggressive treatment can worsen pigmentation. Commonly used devices include low-fluence Q-switched Nd:YAG lasers and, in some cases, picosecond lasers. These work by targeting excess pigment while minimising damage to surrounding skin.
However, lasers are generally not considered first-line therapy. They are best used as part of a broader treatment plan that includes topical and/or oral therapy. When appropriately selected and performed, energy-based treatments can help improve stubborn pigmentation and enhance overall skin tone, but outcomes depend heavily on correct patient selection and medical expertise.
Combination Therapy: The Gold Standard Approach
In modern melasma management, combination therapy is widely regarded as the most effective approach. This is because melasma is driven by multiple factors so targeting only one pathway often leads to incomplete or short-lived results. A well-structured treatment plan typically combines topical agents as the foundation, oral medications for systemic control when appropriate, and carefully selected laser treatments for resistant pigmentation.
The key advantage of combination therapy is synergy: each modality enhances the effectiveness of the others while allowing lower intensity use, which reduces the risk of irritation or rebound pigmentation. Treatment plans are usually tailored based on severity, skin sensitivity, and lifestyle factors, with adjustments made over time. Long-term maintenance is essential, as melasma is a chronic condition that requires ongoing control rather than a one-time intervention.
Conclusion
Melasma is a complex, chronic pigmentation condition that requires a thoughtful and long-term management approach. While it cannot always be completely cured, it can be significantly improved and well controlled with the right combination of topical treatments, oral medications, and selective energy-based procedures.
Understanding triggers such as sun exposure, heat, and skin inflammation is equally important in preventing recurrence and maintaining results. With consistent care and an individualised treatment plan, many patients are able to achieve clearer and more even-toned skin over time. For consultation or treatment planning, you may contact:
One Face Clinic – Pigmentation | Melasma Treatment | Acne Singapore
1 Tras Link, #02-01 Orchid Hotel Singapore, Singapore 078867 | +65 6222 2262
